Vietnam healthcare market a big draw for investors


Later in the year, Hậu Giang Pharmaceutical Joint Stock Company (DHG) became a subsidiary of Japan’s Taisho Pharmaceutical Co Ltd after the latter acquired an additional 20.6 million shares in the former to increase its stake to 50.78 per cent. - Vietnam News/ANN

HANOI: Last year, VinaCapital’s flagship fund, Vietnam Opportunity Fund (VOF), invested US$25 million in a private hospital operator, Tâm Trí Medical Joint Stock Company.

The deal gave VOF a stake in the company, which owns a hospital each in Ho Chi Min, Đồng Tháp Province, Nha Trang City, and Đanang with a total 500 beds and more than 700 employees.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Vietnam , healthcare , investment

Next In Regional

Why China’s humanoid robots are still waiting for their ‘ChatGPT moment’
Singapore turns tide in evolving fight against scams
Africa emerges as new arena in US-China competition over artificial intelligence
China’s parents are outsourcing the homework grind to AI
Where are China’s AI doomers?
China's overstretched healthcare looks to AI boom
Smaller, faster, smarter: Chinese transistor ready for future AI chips
Jimmy Lai to be sentenced on Monday in Hong Kong national security trial
Chinese AI firms defend safety practices, push back on Western criticism
Chinese AI goes next level in geometry at a top US maths Olympiad

Others Also Read